Natural Product: NPC488204

Natural Product IDNPC488204
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
HQJDTNQUMAVTSG-BECFAGSESA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HQJDTNQUMAVTSG-BECFAGSESA-N
Standard InCHI InChI=1S/C95H152O44/c1-16-90(11,121)26-18-20-40(4)78(119)133-72-41(5)126-84(70(116)65(72)111)139-91(12,17-2)27-19-21-39(3)77(118)131-55-32-95(87(120)138-86-76(64(110)59(105)48(34-97)129-86)137-83-71(117)74(135-82-69(115)62(108)58(104)47(33-96)127-82)73(42(6)125-83)134-81-67(113)60(106)49(35-98)128-81)44(30-88(55,7)8)43-22-23-52-92(13)28-25-54(89(9,10)51(92)24-29-93(52,14)94(43,15)31-53(95)101)132-80-68(114)63(109)61(107)50(130-80)38-124-85-75(57(103)46(100)37-123-85)136-79-66(112)56(102)45(99)36-122-79/h16-17,20,22,39,41-42,44-76,79-86,96-117,121H,1-2,18-19,21,23-38H2,3-15H3/b40-20+/t39?,41-,42+,44+,45-,46+,47-,48-,49+,50-,51+,52-,53-,54+,55+,56+,57+,58-,59-,60+,61-,62+,63+,64+,65-,66-,67-,68-,69-,70-,71-,72-,73+,74+,75-,76-,79+,80+,81+,82+,83+,84+,85+,86+,90-,91-,92+,93-,94-,95-/m1/s1
SMILES C=C[C@](C)(CC/C=C(C)/C(=O)O[C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1O)O)O[C@](C)(C=C)CCCC(C)C(=O)O[C@H]1C[C@]2([C@@H](CC1(C)C)C1=CC[C@@H]3[C@@]4(C)CC[C@@H](C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@H]2O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]2[C@@H]([C@H]([C@H](CO2)O)O)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)O1)O)O)O)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@H](C)O1)O[C@H]1[C@@H]([C@H]([C@H](CO)O1)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1996.97 Volume:   1908.756
?
Van der Waals volume.
Dense:   1.046 LogP:   0.454
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.294
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.05
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   36.0 Rigid Bonds:   79.0
TPSA:   682.64
?
Topological Polar Surface Area.
H-Bond Acceptor:   44.0
H-Bond Donor:   23.0 Rings:   13.0
Heavy Atoms:   44.0

MedChem Properties

QED Drug-Likeness Score:   0.01 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   8.579 Fsp3:   0.884
MCE-18:   297.832
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.841 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.001
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.406 Promiscuous compounds:   0.369

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -7.255 MDCK Permeability:   -4.755
Pgp-inhibitor:   0.0 Pgp-substrate:   0.205
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.972
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.003
Plasma Protein Binding (PPB):   53.746% Volume Distribution (VD):   -0.269
Fu: 23.882%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.01
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.952
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -1.781 Half-life (T1/2):  5.253

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  0.672 Drug-induced Liver Injury (DILI):  0.961
AMES Toxicity:  0.997 Rat Oral Acute Toxicity:  0.0
Maximum Recommended Daily Dose:  0.0 Skin Sensitization:  1.0
Carcinogencity:  0.0 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  1.0
Hematotoxicity:  0.6 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  0.158 RPMI-8226 Immunitoxicity:  0.721
A549 Cytotoxicity:  0.996 Hek293 Cytotoxicity:  0.681
BCF:   0.18
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.695
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.136
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.674
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO284 Albizia procera Species Fabaceae Eukaryota Bark n.a. n.a. PMID[30520635]
NPO284 Albizia procera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO284 Albizia procera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3851 Cell line AZ-521 cell line n.a. IC50 = 1200.0 nM PMID[30520635]
NPT116 Cell line HL-60 Homo sapiens IC50 = 900.0 nM PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Ratio = 0.77 n.a. PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Ratio = 0.81 n.a. PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Activity = 104.2 % PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Activity = 106.8 % PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Activity = 80.0 % PMID[30520635]
NPT169 Cell line B16-F10 Mus musculus Activity = 86.2 % PMID[30520635]
NPT134 Cell line SK-BR-3 Homo sapiens IC50 = 800.0 nM PMID[30520635]
NPT81 Cell line A549 Homo sapiens IC50 = 1000.0 nM PMID[30520635]
NPT1374 Cell line WI-38 Homo sapiens IC50 = 8300.0 nM PMID[30520635]
NPT2 Others Unspecified n.a. Ratio IC50 = 8.2 n.a. PMID[30520635]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC488204 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9524 High Similarity NPC488201
0.8571 High Similarity NPC488200
0.8506 High Similarity NPC488203
0.8101 Intermediate Similarity NPC488202
0.8092 Intermediate Similarity NPC311178
0.7848 Intermediate Similarity NPC322904
0.7829 Intermediate Similarity NPC43589
0.7799 Intermediate Similarity NPC324933
0.7756 Intermediate Similarity NPC475444
0.7756 Intermediate Similarity NPC473679
0.7692 Intermediate Similarity NPC222951
0.7605 Intermediate Similarity NPC187497
0.7566 Intermediate Similarity NPC484830
0.7436 Intermediate Similarity NPC300655
0.7423 Intermediate Similarity NPC319719
0.7419 Intermediate Similarity NPC329878
0.7372 Intermediate Similarity NPC233223
0.7372 Intermediate Similarity NPC183816
0.7365 Intermediate Similarity NPC174336
0.7308 Intermediate Similarity NPC484829
0.7273 Intermediate Similarity NPC265699
0.7179 Intermediate Similarity NPC329893
0.7143 Intermediate Similarity NPC475177
0.7 Intermediate Similarity NPC196874
0.6981 Remote Similarity NPC45606
0.6975 Remote Similarity NPC478559
0.6975 Remote Similarity NPC478560
0.6687 Remote Similarity NPC484831
0.6627 Remote Similarity NPC100612
0.6626 Remote Similarity NPC220838
0.6607 Remote Similarity NPC113620
0.6374 Remote Similarity NPC472270
0.6374 Remote Similarity NPC112492
0.6201 Remote Similarity NPC488513
0.619 Remote Similarity NPC13989
0.6105 Remote Similarity NPC23020
0.5988 Remote Similarity NPC297950
0.5951 Remote Similarity NPC33012
0.5931 Remote Similarity NPC232237
0.589 Remote Similarity NPC8524
0.586 Remote Similarity NPC286457
0.5843 Remote Similarity NPC488620
0.5765 Remote Similarity NPC472268
0.5762 Remote Similarity NPC104137
0.5762 Remote Similarity NPC26626
0.5714 Remote Similarity NPC489208
0.5706 Remote Similarity NPC472269
0.5679 Remote Similarity NPC70809
0.5671 Remote Similarity NPC102505
0.5671 Remote Similarity NPC488514
0.5636 Remote Similarity NPC489209
0.5633 Remote Similarity NPC85154
0.5618 Remote Similarity NPC482013
0.5613 Remote Similarity NPC123522
0.557 Remote Similarity NPC105800
0.5563 Remote Similarity NPC13998
0.5556 Remote Similarity NPC207738
0.5466 Remote Similarity NPC473452
0.5432 Remote Similarity NPC470876
0.5419 Remote Similarity NPC488618
0.5389 Remote Similarity NPC488619
0.5333 Remote Similarity NPC309223
0.5269 Remote Similarity NPC220160
0.5229 Remote Similarity NPC488517
0.5197 Remote Similarity NPC488526
0.5127 Remote Similarity NPC210729
0.5127 Remote Similarity NPC82931
0.5089 Remote Similarity NPC224381
0.5079 Remote Similarity NPC475599
0.5027 Remote Similarity NPC485563

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC488204 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data